Goldman Sachs sees M&A growth driven by industry consolidation, its president says-March 2024-www.financetom.com

Goldman Sachs sees M&A growth driven by industry consolidation, its president says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Goldman Sachs sees M&A growth driven by industry consolidation, its president says

Sep 25, 2025 10:20 AM

NEW YORK, Sept 25 (Reuters) - Goldman Sachs ( GS ) is more

optimistic about the outlook for mergers and acquisitions,

fueled by consolidation in various industry sectors and likely

acceleration in private equity-backed deals, its president John

Waldron said on Thursday.

Previous page： TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers Next page： Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

TriSalus Life Sciences, Geo-Med Partner to Expand TriNav Infusion System Access in VA Medical Centers

Nov 11, 2024

07:36 AM EST, 11/11/2024 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Monday that it has partnered with Geo-Med, a certified service-disabled veteran-owned small business, to expand the availability of its TriNav Infusion System across US Department of Veterans Affairs medical centers. The company said Geo-Med is a key supplier to the Veterans Affairs and the US Department...

Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer

Nov 11, 2024

07:33 AM EST, 11/11/2024 (MT Newswires) -- Can-Fite BioPharma ( CANF ) said Monday that the first patient has been dosed in its phase 2a trial of Namodenoson in patients with advanced pancreatic adenocarcinoma. The company said it targets to enroll about 20 evaluable patients in the trial. The study's primary objective is to characterize Namodenoson's safety profile, while the...

GoldMining Up 2.6% In US Premarket As Reports Additional High-Grade Drilling Results and Identified Multiple Drill Targets, Sao Jorge Project, Brazil

Nov 11, 2024

07:36 AM EST, 11/11/2024 (MT Newswires) -- GoldMining Inc. ( GLDG ) was at last look up 2.6% in US premarket trade -- it was even higher -- as the company reported Monday additional assay results from the 2024 auger drilling program at its 100% owned Sao Jorge Project in the Tapajos gold district, Para State, Brazil. Among highlights, it...

Cigna says it will not pursue combination with Humana

Nov 11, 2024

Nov 11 (Reuters) - Health insurer Cigna Group ( CI ) said on Monday it is not pursuing a combination with peer Humana . ...